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SUMMARY – During a two-year period (2001-2003), 464 patients were treated for tuberculosis 
at Jordanovac Department for Lung Diseases in Croatia. Besides pulmonary tuberculosis in 97.7% of 
patients, patients were also treated for tuberculous pleurisy (0.9%), tuberculous laryngitis (0.6%), tu-
berculous meningitis (0.2%), tuberculous pericarditis (0.2%) and urogenital tuberculosis (0.4%). Out 
of the total number of patients, 57.3% declared themselves to be active smokers (men were predomi-
nant and made up to 80.8%) and 20.9% to be active alcohol consumers. Both risk factors, i.e. smoking 
and alcohol consumption, were present in 15.1% of all patients. The most common comorbidities were 
diabetes mellitus (30.4%), cardiac diseases (11.2%) and chronic obstructive pulmonary disease (8.0%). 
Lung carcinoma was the most common malignant disease (n=51), with Mycobacterium tuberculosis 
isolated in 33% of them. Seventy-two of 464 (15.5%) patients had recurrences of tuberculosis. Of 
these, 30.5% had one of the risk factors (20.8% were smokers and 9.7% consumed alcohol), while 
32.5% of patients had both risk factors. In conclusion, cigarette smoking was proved to be the most 
significant risk factor for development of pulmonary tuberculosis and its recurrence.
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Introduction
Tuberculosis is an infectious disease caused by the 
Mycobacterium (M.) tuberculosis bacillus. It may involve 
any organ in the human body, but most commonly af-
fects the lungs (80%-90% of cases)1. Tuberculosis is a 
major public health problem worldwide, and one of 
the top 10 causes of death worldwide, being the lead-
ing cause of death among infectious diseases. Accord-
ing to the latest World Health Organization data, in 
2016, 10.4 million people were infected with tubercu-
losis and 1.3 million people died during the same year2. 
One-quarter of the entire world population are infect-
ed with tuberculosis bacillus3. In 2016, the highest 
number of patients diagnosed with tuberculosis was 
recorded in Asia, followed by African countries. Near-
ly three million people infected with tuberculosis have 
no clear diagnosis and as such remain untreated3,4.
In 2016, a tuberculosis incidence of 12/100,000 in-
habitants was recorded in Croatia, which makes a me-
dium high rate5. Many socioeconomic factors such as 
malnutrition, alcohol abuse and cigarette smoking 
have been recognized as risk factors for the develop-
ment and emergence of active tuberculosis recurrence6.
The aim of our study was to determine the correla-
tion of cigarette smoking and alcohol consumption 
with the incidence and severity of tuberculosis recur-
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rence, and to identify which comorbidity is most com-
monly present in tuberculosis patients.
Patients and Methods
This study was conducted among patients treated 
for tuberculosis at Jordanovac Department for Lung 
Diseases during the 2001-2003 period. Analyzing pa-
tient history, we collected data on age, sex, habits, co-
morbidity and clinical manifestations of tuberculosis 
(pulmonary/extrapulmonary), followed by the number 
of tuberculosis recurrences. In the microbiological lab-
oratory registry, we found data on the number of di-
rectly positive and negative microbiological samples, 
type of microbiological samples, as well as on drug 
susceptibility testing. The study included 464 patients 
treated over two years, with the highest number of pa-
tients in 2003, when 230 patients were treated for tu-
berculosis; all clinical and microbiological indicators 
were analyzed in separate. The study was approved by 
the Ethics Committee of the Jordanovac Department 
for Lung Diseases.
Results
Demographic characteristics of 464 tuberculosis 
patients during the two-year follow-up are presented 
in Table 1. In that period, pulmonary tuberculosis was 
detected in 97.7% and extrapulmonary tuberculosis in 
2.3% of the patients. Additionally, 72 (15.5%) patients 
experienced recurrence of the disease. Out of all pa-
tients with recurrence, 32.5% were tobacco and alcohol 
consumers, 20.8% were tobacco consumers only, 9.7% 
exclusively consumed alcohol, while 37.0% did not 
consume alcohol or tobacco (Table 2). Out of the total 
number of tuberculosis patients, 20.9% consumed al-
cohol, 57.3% were active tobacco smokers and 11.0% 
had ceased smoking just before or during the disease. 
In the active tobacco smokers, the smoking severity 
index expressed in pack-years was 41.5 for men and 
25.2 for women.
When tuberculosis patients were analyzed in a 
one-year period, 230 patients treated for tuberculosis 
in 2003 showed a similar sex distribution, with 143 
(62.1%) men and 87 (37.9%) women. The largest 
number of patients in this period was in the 40-60 age 
group. Pulmonary tuberculosis was diagnosed in 95.2% 
of patients, while 16.9% of patients had extrapulmo-
nary form of tuberculosis, in combination with the 
pulmonary form. The most common extrapulmonary 
form was specific pleuritis in 11.7% (n=27), followed 
by specific lymphadenitis in 3% (n=7), miliary form of 
tuberculosis in 1.3% (n=3) and kidney tuberculosis in 
0.86% (n=2) of patients. Only one (0.43%) patient had 
laryngeal tuberculosis. Out of the total number of pa-
tients, 26.3% had recurrence and 73.5% were directly 
positive. Comorbidities were present in 63.8% of pa-
tients, most commonly diabetes and chronic obstruc-
tive pulmonary disease, which accounted for 12.2% of 
patients, followed by malignancies with 6.5%. Lung 
cancer was the most common malignant disease. M. 
tuberculosis was isolated in 33% of the total number of 
lung cancer patients (n=51). Cigarette smoking was 
present in 51.3% and alcoholism in 36.5% of patients. 
In 73.5% of patients, tuberculosis was diagnosed di-
rectly by microscopy in sputum, catheter aspirate, tu-
mor tissue, lymph node and wound smear. Resistance 
to one or more antituberculotic drugs was demonstrat-
ed by resistance test in ten (4.3%) patients, while 
Table 2. Risk factors among patients with tuberculosis 
recurrence 
Risk factor N =72*n %
Cigarette smoking 15 20.8
Alcohol consumption 7 9.7
Cigarette smoking and alcohol 
consumption 23 32.5
None 27 37.0
*Total number of patients with tuberculosis recurrence: N=72 
(15.5% of 464 patients)
Table 1. Demographic characteristics of tuberculosis 
patients (sex, age and smoking severity index)


















Marina Lampalo et al. Risk factors for tuberculosis development
592 Acta Clin Croat, Vol. 58, No. 4, 2019
multi-drug resistant tuberculosis was found in four 
(1.7%) patients.
Discussion
Despite the progress in modern medicine, tubercu-
losis is still a major clinical problem worldwide. One of 
the most relevant risk factors, as demonstrated in our 
study, was cigarette smoking, with 57.3% of tuberculo-
sis patients reported as active smokers, while 11% of 
patients had ceased smoking just before or during the 
disease. Alcoholism as a risk factor for tuberculosis re-
currence was verified in 20.9% of tuberculosis patients. 
The results are shown for a two-year period during 
which tuberculosis patients were monitored. If tuber-
culosis patients could have been analyzed over a one-
year period, 51.3% of those respondents would be 
cigarette smokers and even 36.5% of them alcohol 
consumers. Given the results obtained in our study, it 
is considered that smokers, compared to non-smokers 
(one-third of cases), have an almost twofold risk of M. 
tuberculosis infection and development of the active 
form of the disease.
More than 20% of tuberculosis prevalence globally 
is associated with smoking, and cigarette smoking in-
creases the risk of developing tuberculosis by almost 
two and a half times7. It has been shown that affected 
patients, at the same time smokers, have more frequent 
disorders such as cough and dyspnea, radiologic bron-
chodynamic dissemination and caverns, and miliary 
tuberculosis as the hematogenic form of the disease. 
Given the great importance of tuberculosis and ciga-
rette smoking association, there are numerous studies 
that have studied this topic. The available data are also 
contradictory as some studies suggest that smoking 
cessation has a positive effect on the control of the dis-
ease itself, whereas others indicate that former smok-
ers have weak immune response at the alveolar macro-
phage level8. Some studies indicate that cigarette 
smoke prevents specific growth and activation of 
CD4+ T cells and lowers CD4+ and CD8+ T cell lev-
els. Other smoking induced mechanisms include oxi-
dative stress due to infection and disturbances in the 
function of tracheobronchial cilia9. More data on this 
topic were obtained by research on mice exposed to 
cigarette smoke and then infected with M. tuberculosis. 
Cigarette smoke exposure amplified the effect of bac-
teria in the infected mice and directly inhibited the 
response of lung T cells to the presence of M. tubercu-
losis in the relevant animal model10.
Our hypothesis was also confirmed by a major study 
on 5567 Taiwan tuberculosis patients, which demon-
strated the impact of cigarette smoking on tuberculosis 
development. Active smokers were twice as likely to 
develop recurrent tuberculosis compared to former 
smokers and individuals who had never consumed to-
bacco products11. Another analytical study from Iran 
showed that 72% of patients infected with M. tubercu-
losis were active smokers. Smoking cessation as a form 
of intervention resulted in 11% reduction of the men-
tioned rate at the time of the next visit. This figure was 
reduced to only 2% several months after treatment12. 
Nearly 1.1 million respondents in India participated in 
the study conducted in 2008, which established that 
tuberculosis mortality rate was 1.7 times higher in 
smokers compared to non-smokers13. In 2009, a group 
of scientists reported an increased risk of mortality by 
60% in more than a million South Korean smokers suf-
fering from tuberculosis14. Another major study in 
Cambodia revealed that the tuberculosis diagnosis was 
more common in men who consumed tobacco prod-
ucts15. The data from many meta-studies from other 
countries and the latest global assessment support the 
fact that the global reduction in tuberculosis infection 
is highly dependent on successful smoking control15.
On the other hand, the study of Gandhy et al. 
among Wistar rats showed that some nicotine analogs 
had anti-mycobacterial effect after oral and parenteral 
administration, believing that nicotine was responsible 
for M. tuberculosis destruction16. The question is why 
there is a high correlation between smoking and prev-
alence of tuberculosis, as stated above. The most likely 
theory is the possibility that nicotine inhibits the pro-
duction of TNFα necrosis factor in pulmonary macro-
phages, and thus the patient becomes more susceptible 
to development of progressive latent infection17. The 
effect of cigarette smoking in patients of different age 
groups was analyzed and compared with the incidence 
of latent tuberculosis18. Older patients were more sus-
ceptible to the negative effect of smoking and develop-
ment of latent disease form. The likelihood ratio was 
significantly higher in older patients than in younger 
ones, and the greatest risk was observed in patients 
aged 56-74, declining slowly after the age of 7518.
Some studies showed that nicotine decreased mac-
rophage ability to destroy M. tuberculosis bacteria. An-
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alyzing the macrophage response to the presence of 
tuberculosis infection, O’Leary et al. compared func-
tional impairment seen in human alveolar macro-
phages from nonsmokers, smokers, and ex-smokers19. 
They observed an inadequate cytokine response to in-
fection in smokers and skewing the inflammatory me-
diator profile of macrophages in the lung, which may 
have affected host susceptibility to the disease19. Bai et 
al. showed that exposure to nicotine impaired the mac-
rophage anti-Mtb defense by inhibition of autophagy 
via binding to nicotinic acetylcholine receptor and ac-
tivation of immunosuppressive Treg cells20. Their next 
study showed that passive smokers also had an in-
creased risk of developing latent and active tuberculo-
sis. This susceptibility may be due to the increased ex-
posure to the tubercle bacilli from the increased cough 
seen in smokers, along with suppressed anti-tubercu-
losis immunity, enhanced activity of immunosuppres-
sive N2 neutrophils or Tregs, or a combination of these 
factors21. Gleeson et al. report on human alveolar mac-
rophages in smokers to be attenuated significantly, 
with consequent impairment of the glycolytic response 
to M. tuberculosis infection, which is crucial in the ear-
ly host immune response to the pathogen22.
The combination of tuberculosis and alcoholism, 
which many consider as the most widespread disease 
of mankind, represents a medical, social and epidemio-
logical problem. The reduced host resistance to the in-
fection is due to the specific lifestyle of alcoholics. 
Mortality among alcohol consuming tuberculosis pa-
tients is significantly higher compared with mortality 
of other infected individuals. Affected alcoholics are a 
significant social and epidemiological problem because 
they often move among large groups of people such as 
waiting rooms and restaurants23,24. A recently pub-
lished study on a mouse model to determine the effects 
of chronic alcohol consumption on immune responses 
during M. tuberculosis infection demonstrated that al-
cohol enhanced IFN-α production by CD11b+Ly6G+ 
cells in the lungs of young Mtb-infected mice, which 
led to macrophage necroptosis and increased mortality. 
Their findings also suggest that young alcoholic indi-
viduals with latent tuberculosis have a higher risk of 
developing active tuberculosis infection25. The preva-
lence of alcoholism among patients with tuberculosis 
is 8%-10%, and there is a significantly higher incidence 
of tuberculosis recurrence among alcoholics. The re-
sults of our study revealed even 20.9% of tuberculosis 
patients to be active alcohol consumers and even 15.1% 
of patients with a combination of cigarette smoking 
and alcohol.
In conclusion, cigarette smoking proved to be the 
most important risk factor for pulmonary tuberculosis 
disease found in 57.3% of patients, and 11.0% of pa-
tients had ceased smoking just before or during the 
disease. Alcoholism as a risk factor for tuberculosis was 
demonstrated in 20.9% of patients. In addition, the 
largest number of patients with tuberculosis recurrence 
was from the smoker group (21%), followed by alcohol 
consumers (10%). Both risk factors, smoking and alco-
hol consumption, accounted for 32.5% of patients 
with recurrent disease. The most common comorbidi-
ties in patients with tuberculosis were chronic obstruc-
tive pulmonary disease, diabetes mellitus, cardiovascu-
lar disease and malignancies.
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Sažetak
ULOGA PUŠENJA I UZIMANJA ALKOHOLNIH PIĆA  
U RAZVOJU I PONAVLJANJU PLUĆNE TUBERKULOZE
M. Lampalo, I. Jukić, J. Bingulac-Popović, H. Safić Stanić, B. Barišić i S. Popović-Grle
Tijekom dvije godine (2001.-2003.) u Klinici za plućne bolesti “Jordanovac”, Zagreb, Hrvatska, od tuberkuloze je liječe-
no 464 bolesnika. Osim najčešće plućne tuberkuloze u 97,7% bolesnika, oboljeli su liječeni i od eksudativnog tuberkuloznog 
pleuritisa (0,9%), laringealne tuberkuloze (0,6%), tuberkuloznog meningitisa (0,2%), perikardijalne tuberkuloze (0,2%) te 
tuberkuloze koja je zahvatila urogenitalni sustav (0,4%). Od ukupnog broja bolesnika 57,3% ih se izjasnilo kao aktivni puša-
či (muškarci 80,8%), dok je 20,9% deklarirano kao aktivni konzumenti alkohola. Ukupno je 15,1% bolesnika imalo oba rizič-
na čimbenika u anamnezi, tj. i aktivno pušenje cigareta i konzumaciju alkohola. Od komorbiditeta najčešća je bila šećerna 
bolest u 30,4% bolesnika, od srčanih bolesti bolovalo je 11,2% bolesnika, dok je kronična opstruktivna plućna bolest bila 
prisutna u 8% bolesnika. Karcinom pluća bio je najčešće zastupljen među malignim bolestima. Od ukupnog broja oboljelih 
od karcinoma pluća (51 bolesnik), Mycobacterium tuberculosis izolirali smo u 33% bolesnika. Recidivi tuberkuloze su zabilje-
ženi u 72 (15,5%) bolesnika. Jedan rizični čimbenik imalo je 30,5% bolesnika: pušača je bilo 20,8%, dok je alkohol konzumi-
ralo 9,7% bolesnika, a 32,5% bolesnika imali su oba rizična čimbenika. Zaključno, pušenje cigareta pokazalo se kao najzna-
čajniji rizični čimbenik za razvoj plućne tuberkuloze, kao i za pojavu recidiva tuberkuloze.
Ključne riječi: Tuberkuloza; Cigarete, pušenje; Alkoholizam; Mycobacterium tuberculosis; Hrvatska
